Johnson & Johnson Medical and Beijing Bethune Charity Foundation launch 2021 China Atrial Fibrillation Day...

Coinciding with the ninth "Chinese Atrial Fibrillation Day", Johnson & Johnson joined hands with Beijing Bethune Charity Foundation to launch the "Medical Road Accompaniment"-2021 China Atrial Fibrillation Day Disease Popularization Public Welfare Communication Project, and launched the "Caring Heart, Love Brain, Healthy Life"—— 2021 China Atrial Fibrillation Day specially planned themed event.

Sun Zhiwei, chairman of the Beijing Bethune Charity Foundation, said in the opening speech of this event: “As a charitable organization focusing on the medical and health field, Beijing Bethune Charity Foundation has always paid attention to heart and brain health, especially the prevention and treatment of atrial fibrillation.

Heart and brain health challenges cannot be ignored, early diagnosis and treatment are the key

In May of this year, the National Bureau of Statistics released the main data of the seventh national census.

Atrial fibrillation is a supraventricular tachyarrhythmia characterized by rapid and disordered atrial electrical activity.

Because some symptoms of atrial fibrillation are not obvious, but the risk of stroke and heart failure is not much or even greater.

In recent years, the advancement of medical technology has provided more and more scientific diagnosis and treatment concepts and methods for atrial fibrillation, making it possible to cure atrial fibrillation.

Exploring the path of healthy China's "heart" and comprehensively boosting heart and brain health

At the moment, "Healthy China" has been elevated to a national strategy.

Yao Yan, deputy director of the Arrhythmia Center of Fuwai Hospital of the Chinese Academy of Medical Sciences and director of the Arrhythmia No.

At present, cardiovascular and cerebrovascular treatment are divided into two different departments.

Among patients with atrial fibrillation, the majority of primary-level patient groups are trapped by disease awareness and local medical resources and service levels, and the treatment situation they face is particularly difficult.

Chen Xi, General Manager of the Cardiovascular and Professional Solutions Division of Johnson & Johnson Medical in China, said: "In addition to continuously bringing innovative treatment methods to patients, Johnson & Johnson Medical has joined hands with various parties to improve the accessibility of atrial fibrillation treatment, such as the county atrial fibrillation center.

In addition, building a multi-level medical security system to help patients reduce the economic burden of disease treatment and further improve the accessibility of treatment is another important way to fully realize heart and brain health.

In this specially planned theme event, young surgeons from the front line of cardiovascular therapy across the country represented Wang Changhui, chief physician of the Department of Cardiovascular Medicine, the First Affiliated Hospital of Anhui Medical University, Wang Changhui, deputy director of the Department, and Director of the First Arrhythmia Department of the First Affiliated Hospital of Dalian Medical University Yin Xiaomeng and Jiang Weifeng, the attending physician of the Department of Cardiology, Shanghai Jiao Tong University Chest Hospital, used ingenious theater-style lectures to vividly share the "heart" story of the doctor-patient relationship in clinical treatment through the intuitive perspective of clinicians, and continue to deliver the correct prevention and treatment of atrial fibrillation.

"Healthy Chinese Heart" requires the joint efforts of the government, medical institutions, doctors, enterprises, and non-profit organizations.